14:43 , Dec 11, 2018 |  BC Innovations  |  Distillery Therapeutics

Neurology

INDICATION: Amyotrophic lateral sclerosis (ALS) Human sample and mouse studies identified a mAb against misfolded SOD1 that could help treat ALS harboring SOD1 mutations. Screening of memory B cells isolated from healthy elderly volunteers for...
20:31 , Dec 16, 2016 |  BC Week In Review  |  Financial News

AL-S Pharma completes venture round

AL-S Pharma raised an undisclosed amount in a venture round from Neurimmune Holding AG and TVM Capital Life Science. AL-S Pharma AG , Zurich, Switzerland ...